GOLM1 and hepatocellular carcinoma: Studies have shown that serum levels of GP73 in HCC patients were significantly higher than those in patients with other severe liver diseases such as cirrhosis and healthy controls [10, 11], indicate that GP73 may be a potential serum marker in the diagnosis of HCC.